MedPath

Normative Assessment of Adaptable Mouthguards.

Not Applicable
Completed
Conditions
Oral Manifestations
Interventions
Device: Adaptable mouthguards
Registration Number
NCT04056559
Lead Sponsor
University Hospital, Bordeaux
Brief Summary

The aim of this study is to the validate adaptable mouthguards prototypes, patented by Bordeaux University and Bordeaux University Hospital.

Detailed Description

The current state of knowledge in the areas of mouthguards shows that type II (adaptable) models account for 90% of the mouthguards of the sporting population. But a majority of these devices do not appear to comply with the European Directive 89/686 / European Economic Community.

A previous work consisted of the production of prototypes of mouthguards meeting the essential requirements of the directive. These prototypes were the subject of a patent filed by the Bordeaux University and the Bordeaux University Hospital.

The aim of this study is to the validate the prototypes for a future launch on the market.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • Subject aged 18 to 35,
  • Subject affiliated to a social security,
  • Subject who has signed the free and informed consent form.
Exclusion Criteria
  • Subject with a pathology incompatible with the performance of the test, namely: Recent infarction,Threat syndrome, blood pressure resting> 200/120 mmHg, uncompensated cardiac insufficiency, atrioventricular block 3rd degree acquired, Myocarditis, Pericarditis, Endocarditis, Aortic Dissection, Intracardiac Tumor or Thrombus, Deep Vein Thrombosis, Pulmonary Embolism,
  • Subject under B-mimetic drug treatment,
  • Subject under safeguard of justice,
  • Subject participating in another search,
  • Subject during pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SIngle armAdaptable mouthguardsThe research is based on a population of men and women practicing a sport at risk of oral trauma.
Primary Outcome Measures
NameTimeMethod
Impact on O2 consumptionAt Week 51

Average of measured values in one minute, compared to reference of the subject

Impact on CO2 productionAt Week 51

Average of measured values in one minute, compared to reference of the subject

Impact on respiratory rateAt Week 51

Average of measured values in one minute, compared to reference of the subject

Impact on comfort according an analogical visual scale for 11 criteriaAt Week 51

According an analogical visual scale (from 0 to 10) for 11 criteria (retention, muco-gingival appearance, mouth opening height, volume of mouthguards, nausea, phonation, open mouth ventilation, tight jaw ventilation, salivation, masticatory muscles, temporomandibular joint)

Impact on current volumeAt Week 51

Average of measured values in one minute, compared to reference of the subject

Impact on ventilatory flow rate by minuteAt Week 51

Average of measured values in one minute, compared to maximum aerobic reference speed of the subject

Modification of the ventilatory flow rate by min

Impact on electromyographic recordingAt Week 52

The electromyographic activity will be amplified and filtered (bandwidth 10-1000 Hz). The signals will be digitized using a CED 1401 interface coupled to a microcomputer that is controlled by the "SPIKE2" software. The digitization frequency will be 2,000 Hz. The software "SPIKE2" will then calculate what is called "integrated electromyogram": the electromyographic signals will be rectified and filtered with a moving average having a period of 0,2 seconds.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath